KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Inventory Average (2016 - 2025)

Historic Inventory Average for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.2 billion.

  • Biogen's Inventory Average fell 1120.15% to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year decrease of 1120.15%. This contributed to the annual value of $2.3 billion for FY2025, which is 720.34% down from last year.
  • As of Q4 2025, Biogen's Inventory Average stood at $2.2 billion, which was down 1120.15% from $2.2 billion recorded in Q3 2025.
  • Over the past 5 years, Biogen's Inventory Average peaked at $2.8 billion during Q4 2023, and registered a low of $1.1 billion during Q1 2021.
  • Its 5-year average for Inventory Average is $1.8 billion, with a median of $1.8 billion in 2022.
  • In the last 5 years, Biogen's Inventory Average soared by 10261.09% in 2023 and then tumbled by 1120.15% in 2025.
  • Over the past 5 years, Biogen's Inventory Average (Quarter) stood at $1.3 billion in 2021, then increased by 0.74% to $1.4 billion in 2022, then surged by 102.61% to $2.8 billion in 2023, then fell by 10.53% to $2.5 billion in 2024, then dropped by 11.2% to $2.2 billion in 2025.
  • Its Inventory Average was $2.2 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $2.3 billion in Q2 2025.